Author Archives: Deal With Cancer Team

PD 0332991 Potentiates Ara-C-Mediated AML Therapy

Cyclin-dependent kinase (CDK)4 and CDK6 are frequently overexpressed or hyperactivated in human cancers. Targeting CDK4/CDK6 in combination with cytotoxic killing therefore represents a rational approach to cancer therapy. By selective inhibition of C...